A newly developed gene therapy shows great potential for treating glaucoma, a condition that can lead to vision loss.

The department is involved in multiple lines of research, which includes investigations into intraocular, structure and function of the optic nerve head with glaucomatous damage, basic and clinical ...

Initiation of IOP reduction therapy fails to improve Visual field status in glaucoma patients suggests a study published in ...

Glaucoma is the leading cause of irreversible visual loss, driven by a neurodegenerative process that affects the ganglion cells and their axons, leading to remodeling and excavation of the optic ...

Increased intraocular pressure (lOP) is recognised as the principal risk factor for the development of glaucomatous cupping of the optic disc. The hypothesis that it disrupts the function of ...

Headaches that present to an ophthalmologist include migraine, facial pain syndromes, and pain associated with cranial neuropathies, orbital, and ocular disease. Some headaches are symptoms of ...

Mitochondrial dysfunction has been strongly implicated in glaucomatous neurodegeneration in patients as well as multiple models of glaucoma (eye disease). Many types of mitochondrial disorders are ...

This clinical placement experience became the subject of her honours thesis: analyzing the repeatability of a system that detects early-stage glaucomatous damage – the leading cause of irreversible ...